As the Premier League season nears its conclusion, who are favourites to secure a place in Europe next season, and how many ...
April 27 (Reuters) - Eli Lilly said on Monday it would buy privately-held blood cancer treatment developer Ajax ...
The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.
Eli Lilly is continuing its Massachusetts shopping spree, picking up a Cambridge biotech focused on blood cancer treatments ...
Francesco Farioli appears to have ruled himself out of the running to manage Chelsea (Picture: sport tv) Francesco Farioli ...
Eli Lilly LLY0.87%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...
Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax ...
Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...
Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...
April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results